EIisa –a connected, affordable light solution for treating sleep apnea.

Información del proyecto

SUNRISE Tx

Identificador del acuerdo de subvención: 190180051

DOI

10.3030/190180051

Proyecto cerrado

Fecha de la firma de la CE 29 Junio 2022

Fecha de inicio 1 Julio 2022

Fecha de finalización 31 Diciembre 2024

Financiado con arreglo a

• The European Innovation Council (EIC)

Coste total

€ 2 771 250,78

Aportación de la UE

€ 1 939 875,00

Coordinado por

SUNRISE
Belgium

Periodic Reporting for period 2 - SUNRISE Tx (EIisa –a connected, affordable light solution for treating sleep apnea.)

Período documentado: 2023-07-01 hasta 2024-12-31

Resumen del contexto y de los objetivos generales del proyecto

Sleep apnea is a common sleep disorder characterized by repeated interruptions in breathing during sleep. It is a major comorbidity of cardiovascular disease and a significant risk factor for type 2 diabetes, stroke, coronary artery disease, congestive heart failure, and atrial fibrillation, among other conditions. The current gold standard treatment relies on positive airway pressure (PAP) devices, which often cause discomfort, as they require patients to wear a face mask connected to a hose throughout the night. The Sunrise Tx project introduces the first truly comfortable, non-invasive, cost-effective, and accessible solution for sleep apnea treatment. Sunrise Tx is designed to broaden access to personalized therapy, improve patient compliance, and provide millions of people worldwide with a more comfortable and effective solution for managing their sleep apnea.

Trabajo realizado desde el comienzo del proyecto hasta el final del período abarcado por el informe y los principales resultados hasta la fecha

The activities focused on refining the design and enhancing patient comfort for the Sunrise Tx device. Through extensive research and multiple design iterations, significant advancements were achieved, resulting in a markedly improved user experience. A rigorous clinical validation process was implemented to thoroughly assess the device’s efficacy and safety. The validation results demonstrated strong clinical value, earning widespread support from the medical community.

Avances que van más allá del estado de la técnica e impacto potencial esperado (incluida la repercusión socioeconómica y las implicaciones sociales más amplias del proyecto hasta la fecha)

The Sunrise Tx project surpasses the current state of the art in sleep apnea treatment by offering a non-invasive, cost-effective, and patient-centered solution that overcomes the limitations of conventional PAP therapies. Building on its validated efficacy and safety, the device integrates innovative design and personalized therapy to significantly enhance comfort, usability, and patient compliance, addressing key barriers to long-term adherence. Beyond improving the user experience, Sunrise Tx expands access to effective care, providing a practical and scalable solution for millions of patients. By combining technological innovation with a patient-centric approach, Sunrise Tx represents a transformative advancement in sleep apnea management, setting a new standard in therapeutic care.

SUNRISE logo